Prospective, randomized multi-centre, study to compare the effectiveness, safety and tolerability of Lulican shampoo versus ketoconazole shampoo, in Indian adult patients with mild to moderate scalp Seborrheic Dermatitis (LEAD Study). - LEAD Study

Anisha Clinic0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1. Adult patients (18-65 yrs) diagnosed with scalp seborrheic dermatitis and candidates for shampoo therapy at the discretion by treating physician
•2. Willing to use shampoo thrice a week as advised
•3. Willing to avoid oil application for study duration
•4. Patients willing to refrain from other forms of treatment including other topical, oral medication for seborrheic dermatitis
•5. Patients who are willing to appear for regular follow ups and follow the prescribed treatment regularly
•6. Patients who are willing to give consent to participate in the study

•1. Pregnant/ Planning to conceive/ Lactating women
•2. Immunocompromised patients on corticosteroids, other immunosuppressive or biologic drugs
•3. Patients suffering from infectious, auto-immune, or other disorders affecting skin of scalp.
•4. Documented and known history of severe systemic disease, necessitating medical treatment, as assessed by the investigator that might interfere with the conduct of the study or the interpretation of results.
•5. Patients known to be allergic to the any of the components of the study medications.
•6. Use of any topical medication including OTC products for dandruff within 14 days of enrolment.
•7. Patients who are receiving drugs which are known to affect scalp or hair.
•8. Patients with known malignancy.
•9. Refusal to participate in the study.

发起方

Anisha Clinic